New advancements in IOL technology is exciting for presbyopia treatment

Catching up after ASCRS 2022, Ora's Caitlin Black, senior director and therapeutic area head of medical devices, talks about the next generation of ophthalmic device therapies and diagnostics, clinical trial updates and new innovations that are most exciting for presbyopia treatment.

Retrospective study shows toric IOL rotation rate to be low at 2.1%

Edward Hu, MD, PhD, looked at 812 toric IOLs utilized of various platforms, concluding a low total toric rotation rate at 2.1%.

Surgical options for normalizing neuroadaptation in patients

Technical details, communication style key to presbyopia-correcting IOL journey.